| Ticker Symbol: | OCLS |
|---|---|
| Exchange: | NASD |
| Contact Info: | 1129 N. McDowell Blvd. Petaluma, CA 94954 (707) 782-0792 |
| CEO/President: | Hojabr Alimi |
| Industry: | Medical Instruments Supls / Standard Industry Code: 3841 |
| Description: | The Company develops, manufactures and markets a family of products intended to prevent and treat infections in chronic and acute wounds. |
| Shares Outstanding: | 15,906 (000) | Market Value: | 38,376 ($000) |
|---|---|---|---|
| Percentage of Inst.Shareholders: | 21.0% | Number of Inst.Shareholders: | 21 |
| Last Quarter Sales: | .9 ($Mil.) | Last Quarter Net Income: | -4.5 ($Mil.) |
| Last Quarter EPS: | -.34 | P/E Ratio: | NE |
| Most Recent Earnings: | Earnings Per Share: | -1.60 | |
| Most Recent Split: | Annual Dividend Rate: | .00 | |
| Most Recent Dividend: | Annual Dividend Yield: | .0% |

| BOSTON SCIENTIF | -17.20 | 12.35 | |
| BAXTER INTL INC | +15.40 | 64.12 | |
| COVIDIEN LTD | +16.00 | 47.89 | |
| BECTON DICKINSO | +6.70 | 82.35 | |
| STRYKER CP | -7.10 | 62.50 |
